Trovagene launches pharmaceutical alliance to monitor lung cancer patients … – News-Medical.net

by lowes1 on October 16, 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients
News-Medical.net
Lung cancer is the most prevalent cancer in the United States, with more than 225,000 new cases diagnosed annually. EGFR mutations are present in 10 to 35 percent of lung cancers, and these mutations frequently occur during the course of therapy, 

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: